, (Integr Med (Encinitas)
Brand-name weekly injectables (Wegovy semaglutide, Zepbound tirzepatide) typically list between about $1,000 and $1,400 per 28-day supply when paid out of pocket, depending on dose and pharmacy
Clinical trials of semaglutide and dulaglutide have demonstrated A1c reductions of 1.0% to 1.5% or more from baseline after three to six months of treatment
In women with PCOS, disordered appetite and weight regulation often coexist with menstrual dysfunction
[7] This decline correlates directly with increased oxidative stress markers and age-related health issues
Depending on the reason, the next move might be: Resubmitting with better documentation Trying a different covered medication Completing the required lifestyle program over the next 3 to 6 months Filing a formal appeal with new clinical evidence Switching to cash-pay or manufacturer programs Pausing the GLP-1 path and addressing an underlying mental health, hormonal, or metabolic issue first Considering a different FDA-approved weight loss medication The right next step depends on your specific plan, BMI, health history, prior medication trials, and treatment goals